{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:41:32Z","timestamp":1761986492169,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":41,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493932702"},{"type":"electronic","value":"9781493932719"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3271-9_27","type":"book-chapter","created":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T06:47:47Z","timestamp":1448520467000},"page":"383-395","source":"Crossref","is-referenced-by-count":4,"title":["Gene Therapy-Based Modeling of Neurodegenerative Disorders: Huntington\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Deborah","family":"Young","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"20","key":"27_CR1","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1056\/NEJM198611133152006","volume":"315","author":"JB Martin","year":"1986","unstructured":"Martin JB, Gusella JF (1986) Huntington\u2019s disease. Pathogenesis and management. N Engl J Med 315(20):1267\u20131276. doi:10.1056\/NEJM198611133152006","journal-title":"N Engl J Med"},{"key":"27_CR2","doi-asserted-by":"crossref","unstructured":"(1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell 72(6):971\u2013983. doi:0092-8674(93)90585-E [pii]","DOI":"10.1016\/0092-8674(93)90585-E"},{"issue":"15","key":"27_CR3","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","volume":"85","author":"A Reiner","year":"1988","unstructured":"Reiner A, Albin RL, Anderson KD, D\u2019Amato CJ, Penney JB, Young AB (1988) Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A 85(15):5733\u20135737","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"27_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57(5):369\u2013384","journal-title":"J Neuropathol Exp Neurol"},{"issue":"10","key":"27_CR5","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/nrn3570","volume":"14","author":"MA Pouladi","year":"2013","unstructured":"Pouladi MA, Morton AJ, Hayden MR (2013) Choosing an animal model for the study of Huntington\u2019s disease. Nat Rev Neurosci 14(10):708\u2013721. doi:10.1038\/nrn3570","journal-title":"Nat Rev Neurosci"},{"issue":"5577","key":"27_CR6","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/263517a0","volume":"263","author":"EG McGeer","year":"1976","unstructured":"McGeer EG, McGeer PL (1976) Duplication of biochemical changes of Huntington\u2019s chorea by intrastriatal injections of glutamic and kainic acids. Nature 263(5577):517\u2013519","journal-title":"Nature"},{"issue":"1-2","key":"27_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0006-8993(85)91283-1","volume":"361","author":"MF Beal","year":"1985","unstructured":"Beal MF, Marshall PE, Burd GD, Landis DM, Martin JB (1985) Excitotoxin lesions do not mimic the alteration of somatostatin in Huntington\u2019s disease. Brain Res 361(1-2):135\u2013145","journal-title":"Brain Res"},{"issue":"6066","key":"27_CR8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/321168a0","volume":"321","author":"MF Beal","year":"1986","unstructured":"Beal MF, Kowall NW, Ellison DW, Mazurek MF, Swartz KJ, Martin JB (1986) Replication of the neurochemical characteristics of Huntington\u2019s disease by quinolinic acid. Nature 321(6066):168\u2013171. doi:10.1038\/321168a0","journal-title":"Nature"},{"issue":"2","key":"27_CR9","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1006\/exnr.1993.1197","volume":"124","author":"RC Roberts","year":"1993","unstructured":"Roberts RC, Ahn A, Swartz KJ, Beal MF, DiFiglia M (1993) Intrastriatal injections of quinolinic acid or kainic acid: differential patterns of cell survival and the effects of data analysis on outcome. Exp Neurol 124(2):274\u2013282. doi:10.1006\/exnr.1993.1197, S0014-4886(83)71197-0 [pii]","journal-title":"Exp Neurol"},{"issue":"3","key":"27_CR10","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/j.1471-4159.1993.tb03633.x","volume":"61","author":"MF Beal","year":"1993","unstructured":"Beal MF, Brouillet E, Jenkins B, Henshaw R, Rosen B, Hyman BT (1993) Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate. J Neurochem 61(3):1147\u20131150","journal-title":"J Neurochem"},{"issue":"1-2","key":"27_CR11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/0006-8993(95)00901-2","volume":"697","author":"CV Borlongan","year":"1995","unstructured":"Borlongan CV, Koutouzis TK, Freeman TB, Cahill DW, Sanberg PR (1995) Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington\u2019s disease. Brain Res 697(1-2):254\u2013257, doi:0006-8993(95)00901-2 [pii]","journal-title":"Brain Res"},{"issue":"1","key":"27_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0306-4522(96)00602-1","volume":"79","author":"MC Guyot","year":"1997","unstructured":"Guyot MC, Hantraye P, Dolan R, Palfi S, Maziere M, Brouillet E (1997) Quantifiable bradykinesia, gait abnormalities and Huntington\u2019s disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid. Neuroscience 79(1):45\u201356, doi:S0306452296006021 [pii]","journal-title":"Neuroscience"},{"issue":"1","key":"27_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1073\/pnas.96.1.179","volume":"96","author":"PW Faber","year":"1999","unstructured":"Faber PW, Alter JR, MacDonald ME, Hart AC (1999) Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. Proc Natl Acad Sci U S A 96(1):179\u2013184","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"27_CR14","doi-asserted-by":"publisher","first-page":"13318","DOI":"10.1073\/pnas.231476398","volume":"98","author":"JA Parker","year":"2001","unstructured":"Parker JA, Connolly JB, Wellington C, Hayden M, Dausset J, Neri C (2001) Expanded polyglutamines in Caenorhabditis elegans cause axonal abnormalities and severe dysfunction of PLM mechanosensory neurons without cell death. Proc Natl Acad Sci U S A 98(23):13318\u201313323. doi:10.1073\/pnas.231476398","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"27_CR15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0896-6273(00)80573-5","volume":"21","author":"GR Jackson","year":"1998","unstructured":"Jackson GR, Salecker I, Dong X, Yao X, Arnheim N, Faber PW, MacDonald ME, Zipursky SL (1998) Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 21(3):633\u2013642","journal-title":"Neuron"},{"issue":"9","key":"27_CR16","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1073\/pnas.0400243101","volume":"101","author":"WC Lee","year":"2004","unstructured":"Lee WC, Yoshihara M, Littleton JT (2004) Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington\u2019s disease. Proc Natl Acad Sci U S A 101(9):3224\u20133229. doi:10.1073\/pnas.0400243101","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6857","key":"27_CR17","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/35099568","volume":"413","author":"JS Steffan","year":"2001","unstructured":"Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, Kazantsev A, Schmidt E, Zhu YZ, Greenwald M, Kurokawa R, Housman DE, Jackson GR, Marsh JL, Thompson LM (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413(6857):739\u2013743. doi:10.1038\/35099568","journal-title":"Nature"},{"issue":"1","key":"27_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","volume":"23","author":"JG Hodgson","year":"1999","unstructured":"Hodgson JG, Agopyan N, Gutekunst CA, Leavitt BR, LePiane F, Singaraja R, Smith DJ, Bissada N, McCutcheon K, Nasir J, Jamot L, Li XJ, Stevens ME, Rosemond E, Roder JC, Phillips AG, Rubin EM, Hersch SM, Hayden MR (1999) A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23(1):181\u2013192, doi:S0896-6273(00)80764-3 [pii]","journal-title":"Neuron"},{"issue":"2","key":"27_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","volume":"10","author":"CH Lin","year":"2001","unstructured":"Lin CH, Tallaksen-Greene S, Chien WM, Cearley JA, Jackson WS, Crouse AB, Ren S, Li XJ, Albin RL, Detloff PJ (2001) Neurological abnormalities in a knock-in mouse model of Huntington\u2019s disease. Hum Mol Genet 10(2):137\u2013144","journal-title":"Hum Mol Genet"},{"issue":"3","key":"27_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87(3):493\u2013506, doi:S0092-8674(00)81369-0 [pii]","journal-title":"Cell"},{"issue":"18","key":"27_CR21","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1523\/JNEUROSCI.22-18-08266.2002","volume":"22","author":"LB Menalled","year":"2002","unstructured":"Menalled LB, Sison JD, Wu Y, Olivieri M, Li XJ, Li H, Zeitlin S, Chesselet MF (2002) Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington\u2019s disease knock-in mice. J Neurosci 22(18):8266\u20138276, 22\/18\/8266 [pii]","journal-title":"J Neurosci"},{"issue":"5","key":"27_CR22","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/hmg\/8.5.763","volume":"8","author":"PF Shelbourne","year":"1999","unstructured":"Shelbourne PF, Killeen N, Hevner RF, Johnston HM, Tecott L, Lewandoski M, Ennis M, Ramirez L, Li Z, Iannicola C, Littman DR, Myers RM (1999) A Huntington\u2019s disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice. Hum Mol Genet 8(5):763\u2013774, doi:ddc104 [pii]","journal-title":"Hum Mol Genet"},{"issue":"2-3","key":"27_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.brainresbull.2011.07.009","volume":"88","author":"Z Bayram-Weston","year":"2012","unstructured":"Bayram-Weston Z, Jones L, Dunnett SB, Brooks SP (2012) Light and electron microscopic characterization of the evolution of cellular pathology in the R6\/1 Huntington\u2019s disease transgenic mice. Brain Res Bull 88(2-3):104\u2013112. doi:10.1016\/j.brainresbull.2011.07.009","journal-title":"Brain Res Bull"},{"issue":"13","key":"27_CR24","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y, Oh R, Bissada N, Hossain SM, Yang YZ, Li XJ, Simpson EM, Gutekunst CA, Leavitt BR, Hayden MR (2003) Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 12(13):1555\u20131567","journal-title":"Hum Mol Genet"},{"issue":"4","key":"27_CR25","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/cne.20680","volume":"490","author":"EC Stack","year":"2005","unstructured":"Stack EC, Kubilus JK, Smith K, Cormier K, Del Signore SJ, Guelin E, Ryu H, Hersch SM, Ferrante RJ (2005) Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington\u2019s disease transgenic mice. J Comp Neurol 490(4):354\u2013370. doi:10.1002\/cne.20680","journal-title":"J Comp Neurol"},{"issue":"24","key":"27_CR26","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","volume":"28","author":"M Gray","year":"2008","unstructured":"Gray M, Shirasaki DI, Cepeda C, Andre VM, Wilburn B, Lu XH, Tao J, Yamazaki I, Li SH, Sun YE, Li XJ, Levine MS, Yang XW (2008) Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci 28(24):6182\u20136195. doi:10.1523\/JNEUROSCI.0857-08.2008","journal-title":"J Neurosci"},{"issue":"44","key":"27_CR27","doi-asserted-by":"publisher","first-page":"15426","DOI":"10.1523\/JNEUROSCI.1148-12.2012","volume":"32","author":"L Yu-Taeger","year":"2012","unstructured":"Yu-Taeger L, Petrasch-Parwez E, Osmand AP, Redensek A, Metzger S, Clemens LE, Park L, Howland D, Calaminus C, Gu X, Pichler B, Yang XW, Riess O, Nguyen HP (2012) A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease. J Neurosci 32(44):15426\u201315438. doi:10.1523\/JNEUROSCI.1148-12.2012","journal-title":"J Neurosci"},{"issue":"3","key":"27_CR28","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.nbd.2005.05.017","volume":"20","author":"D Zala","year":"2005","unstructured":"Zala D, Benchoua A, Brouillet E, Perrin V, Gaillard MC, Zurn AD, Aebischer P, Deglon N (2005) Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment. Neurobiol Dis 20(3):785\u2013798. doi:10.1016\/j.nbd.2005.05.017","journal-title":"Neurobiol Dis"},{"issue":"3","key":"27_CR29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/jgm.1150","volume":"10","author":"B Huang","year":"2008","unstructured":"Huang B, Schiefer J, Sass C, Kosinski CM, Kochanek S (2008) Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion. J Gene Med 10(3):269\u2013279. doi:10.1002\/jgm.1150","journal-title":"J Gene Med"},{"issue":"1","key":"27_CR30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1523\/JNEUROSCI.20-01-00219.2000","volume":"20","author":"MC Senut","year":"2000","unstructured":"Senut MC, Suhr ST, Kaspar B, Gage FH (2000) Intraneuronal aggregate formation and cell death after viral expression of expanded polyglutamine tracts in the adult rat brain. J Neurosci 20(1):219\u2013229","journal-title":"J Neurosci"},{"issue":"9","key":"27_CR31","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1523\/JNEUROSCI.22-09-03473.2002","volume":"22","author":"LP de Almeida","year":"2002","unstructured":"de Almeida LP, Ross CA, Zala D, Aebischer P, Deglon N (2002) Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length. J Neurosci 22(9):3473\u20133483, doi:20026337","journal-title":"J Neurosci"},{"issue":"5","key":"27_CR32","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/mt.2008.50","volume":"16","author":"NR Franich","year":"2008","unstructured":"Franich NR, Fitzsimons HL, Fong DM, Klugmann M, During MJ, Young D (2008) AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington\u2019s disease. Mol Ther 16(5):947\u2013956. doi:10.1038\/mt.2008.50","journal-title":"Mol Ther"},{"issue":"43","key":"27_CR33","doi-asserted-by":"publisher","first-page":"17204","DOI":"10.1073\/pnas.0708285104","volume":"104","author":"M DiFiglia","year":"2007","unstructured":"DiFiglia M, Sena-Esteves M, Chase K, Sapp E, Pfister E, Sass M, Yoder J, Reeves P, Pandey RK, Rajeev KG, Manoharan M, Sah DW, Zamore PD, Aronin N (2007) Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc Natl Acad Sci U S A 104(43):17204\u201317209. doi:10.1073\/pnas.0708285104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"27_CR34","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ana.21569","volume":"65","author":"V Drouet","year":"2009","unstructured":"Drouet V, Perrin V, Hassig R, Dufour N, Auregan G, Alves S, Bonvento G, Brouillet E, Luthi-Carter R, Hantraye P, Deglon N (2009) Sustained effects of nonallele-specific Huntingtin silencing. Ann Neurol 65(3):276\u2013285. doi:10.1002\/ana.21569","journal-title":"Ann Neurol"},{"issue":"21","key":"27_CR35","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1093\/hmg\/ddg305","volume":"12","author":"E Regulier","year":"2003","unstructured":"Regulier E, Trottier Y, Perrin V, Aebischer P, Deglon N (2003) Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatum. Hum Mol Genet 12(21):2827\u20132836. doi:10.1093\/hmg\/ddg305","journal-title":"Hum Mol Genet"},{"issue":"6","key":"27_CR36","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00005072-198511000-00003","volume":"44","author":"JP Vonsattel","year":"1985","unstructured":"Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, Richardson EP Jr (1985) Neuropathological classification of Huntington\u2019s disease. J Neuropathol Exp Neurol 44(6):559\u2013577","journal-title":"J Neuropathol Exp Neurol"},{"issue":"15","key":"27_CR37","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1093\/hmg\/ddq212","volume":"19","author":"M Faideau","year":"2010","unstructured":"Faideau M, Kim J, Cormier K, Gilmore R, Welch M, Auregan G, Dufour N, Guillermier M, Brouillet E, Hantraye P, Deglon N, Ferrante RJ, Bonvento G (2010) In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington\u2019s disease subjects. Hum Mol Genet 19(15):3053\u20133067. doi:10.1093\/hmg\/ddq212","journal-title":"Hum Mol Genet"},{"issue":"8","key":"27_CR38","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/sj.mt.6300185","volume":"15","author":"S Palfi","year":"2007","unstructured":"Palfi S, Brouillet E, Jarraya B, Bloch J, Jan C, Shin M, Conde F, Li XJ, Aebischer P, Hantraye P, Deglon N (2007) Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates. Mol Ther 15(8):1444\u20131451. doi:10.1038\/sj.mt.6300185","journal-title":"Mol Ther"},{"issue":"4","key":"27_CR39","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/0306-4522(94)00431-4","volume":"64","author":"LH Burns","year":"1995","unstructured":"Burns LH, Pakzaban P, Deacon TW, Brownell AL, Tatter SB, Jenkins BG, Isacson O (1995) Selective putaminal excitotoxic lesions in non-human primates model the movement disorder of Huntington disease. Neuroscience 64(4):1007\u20131017","journal-title":"Neuroscience"},{"issue":"7197","key":"27_CR40","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nature06975","volume":"453","author":"SH Yang","year":"2008","unstructured":"Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, Cheng EC, Snyder B, Larkin K, Liu J, Orkin J, Fang ZH, Smith Y, Bachevalier J, Zola SM, Li SH, Li XJ, Chan AW (2008) Towards a transgenic model of Huntington\u2019s disease in a non-human primate. Nature 453(7197):921\u2013924. doi:10.1038\/nature06975","journal-title":"Nature"},{"key":"27_CR41","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1986","unstructured":"Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic, San Diego"}],"container-title":["Methods in Molecular Biology","Gene Therapy for Neurological Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3271-9_27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T13:36:18Z","timestamp":1676036178000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4939-3271-9_27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493932702","9781493932719"],"references-count":41,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3271-9_27","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2016]]}}}